Viatris Inc. (FRA:VIA)

Germany flag Germany · Delayed Price · Currency is EUR
8.00
0.00 (0.00%)
Last updated: Jul 31, 2025
Market Cap9.20B
Revenue (ttm)13.26B
Net Income (ttm)-3.51B
Shares Outn/a
EPS (ttm)-2.94
PE Ration/a
Forward PE3.98
Dividend0.44 (5.49%)
Ex-Dividend DateMay 23, 2025
Volumen/a
Average Volume3
Open8.00
Previous Close8.00
Day's Range8.00 - 8.00
52-Week Range6.53 - 12.73
Betan/a
RSI62.22
Earnings DateAug 7, 2025

About Blueprint Medicines

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CN... [Read more]

Industry Pharmaceutical Preparations
Founded 1961
Employees 32,000
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol VIA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.